Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)
Clinical trial NCT04105010 · COMPLETED
Trial details
- NCT number
- NCT04105010
- Sponsor
- Dizal Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2023-10-12
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.